MedPath

A preliminary study comparing daily use of home-based hand-held Narrow Band UVB comb device versus biweekly hospital-based excimer light therapy in treatment of localized vitiligo

Not Applicable
Conditions
Health Condition 1: L80- Vitiligo
Registration Number
CTRI/2021/11/037885
Lead Sponsor
AIIMS New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Consecutive patients of localized vitiligo i.e. <=2% BSA or <=10 patches.

2. Patients >=18 years of age.

3. Patients who have not taken any topical therapy in last 2 weeks or systemic therapy in last 4 weeks

4. Patients giving consent for using hand held NB-UVB/excimer light

Exclusion Criteria

1. Patients with rapidly spreading vitiligo i.e.development of >= 5 new lesions in the past 1 month or >= 15 lesions in the past 3 months.

2. Patients with recalcitrant forms of vitiligo i.e., lip-tip vitiligo, segmental vitiligo, genital vitiligo and with predominant leukotrichia on patches.

3. Patients with concomitant photo-aggravated dermatoses.

4. Patients who are unable to adhere to instructions on use of the hand-held NB-UVB comb device or maintain it or patients unable to visit the hospital for excimer light therapy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath